Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Adalimumab Biosimilar Market Analysis 2015-2019 and Forecast 2020-2025

  • 99S3474161
  • 94 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
Snapshot

The global Adalimumab Biosimilar market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Adalimumab Biosimilar by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Tablet

Oral Solution

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

AET BioTech

Amgen

Boehringer Ingelheim

Coherus Biosciences

Fujifilm Kyowa Kirin Biologics

LG Life Sciences/Mochida Pharmaceutical

Momenta Pharmaceuticals

Oncobiologics

Pfizer

Samsung Bioepsis

Sandoz

Zydus Cadila

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Content

1 Industry Overview

1.1 Adalimumab Biosimilar Industry

Figure Adalimumab Biosimilar Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Adalimumab Biosimilar

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Adalimumab Biosimilar

1.2.2 Downstream

Table Application Segment of Adalimumab Biosimilar

Table Global Adalimumab Biosimilar Market 2015-2025, by Application, in USD Million

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Adalimumab Biosimilar Market by Type

3.1 By Type

3.1.1 Tablet

Table Major Company List of Tablet

3.1.2 Oral Solution

Table Major Company List of Oral Solution

3.2 Market Size

Table Global Adalimumab Biosimilar Market 2015-2019, by Type, in USD Million

Figure Global Adalimumab Biosimilar Market Growth 2015-2019, by Type, in USD Million

Table Global Adalimumab Biosimilar Market 2015-2019, by Type, in Volume

Figure Global Adalimumab Biosimilar Market Growth 2015-2019, by Type, in Volume

3.3 Market Forecast

Table Global Adalimumab Biosimilar Market Forecast 2020-2025, by Type, in USD Million

Table Global Adalimumab Biosimilar Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

4.1 AET BioTech (Company Profile, Sales Data etc.)

4.1.1 AET BioTech Profile

Table AET BioTech Overview List

4.1.2 AET BioTech Products & Services

4.1.3 AET BioTech Business Operation Conditions

Table Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 Amgen (Company Profile, Sales Data etc.)

4.2.1 Amgen Profile

Table Amgen Overview List

4.2.2 Amgen Products & Services

4.2.3 Amgen Business Operation Conditions

Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Boehringer Ingelheim (Company Profile, Sales Data etc.)

4.3.1 Boehringer Ingelheim Profile

Table Boehringer Ingelheim Overview List

4.3.2 Boehringer Ingelheim Products & Services

4.3.3 Boehringer Ingelheim Business Operation Conditions

Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Coherus Biosciences (Company Profile, Sales Data etc.)

4.4.1 Coherus Biosciences Profile

Table Coherus Biosciences Overview List

4.4.2 Coherus Biosciences Products & Services

4.4.3 Coherus Biosciences Business Operation Conditions

Table Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Fujifilm Kyowa Kirin Biologics (Company Profile, Sales Data etc.)

4.5.1 Fujifilm Kyowa Kirin Biologics Profile

Table Fujifilm Kyowa Kirin Biologics Overview List

4.5.2 Fujifilm Kyowa Kirin Biologics Products & Services

4.5.3 Fujifilm Kyowa Kirin Biologics Business Operation Conditions

Table Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 LG Life Sciences/Mochida Pharmaceutical (Company Profile, Sales Data etc.)

4.6.1 LG Life Sciences/Mochida Pharmaceutical Profile

Table LG Life Sciences/Mochida Pharmaceutical Overview List

4.6.2 LG Life Sciences/Mochida Pharmaceutical Products & Services

4.6.3 LG Life Sciences/Mochida Pharmaceutical Business Operation Conditions

Table Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Momenta Pharmaceuticals (Company Profile, Sales Data etc.)

4.7.1 Momenta Pharmaceuticals Profile

Table Momenta Pharmaceuticals Overview List

4.7.2 Momenta Pharmaceuticals Products & Services

4.7.3 Momenta Pharmaceuticals Business Operation Conditions

Table Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 Oncobiologics (Company Profile, Sales Data etc.)

4.8.1 Oncobiologics Profile

Table Oncobiologics Overview List

4.8.2 Oncobiologics Products & Services

4.8.3 Oncobiologics Business Operation Conditions

Table Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.9 Pfizer (Company Profile, Sales Data etc.)

4.9.1 Pfizer Profile

Table Pfizer Overview List

4.9.2 Pfizer Products & Services

4.9.3 Pfizer Business Operation Conditions

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.10 Samsung Bioepsis (Company Profile, Sales Data etc.)

4.10.1 Samsung Bioepsis Profile

Table Samsung Bioepsis Overview List

4.10.2 Samsung Bioepsis Products & Services

4.10.3 Samsung Bioepsis Business Operation Conditions

Table Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.11 Sandoz (Company Profile, Sales Data etc.)

4.11.1 Sandoz Profile

Table Sandoz Overview List

4.11.2 Sandoz Products & Services

4.11.3 Sandoz Business Operation Conditions

Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.12 Zydus Cadila (Company Profile, Sales Data etc.)

4.12.1 Zydus Cadila Profile

Table Zydus Cadila Overview List

4.12.2 Zydus Cadila Products & Services

4.12.3 Zydus Cadila Business Operation Conditions

Table Business Operation of Zydus Cadila (Sales Revenue, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Adalimumab Biosimilar Sales Revenue 2015-2019, by Company, in USD Million

Table Global Adalimumab Biosimilar Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global Adalimumab Biosimilar Sales Revenue Share in 2019, by Company, in USD Million

Table Global Adalimumab Biosimilar Sales Volume 2015-2019, by Company, in Volume

Table Global Adalimumab Biosimilar Sales Volume Share 2015-2019, by Company, in Volume

Figure Global Adalimumab Biosimilar Sales Volume Share in 2019, by Company, in Volume

5.2 Regional Market by Company

Figure North America Adalimumab Biosimilar Market Concentration, in 2019

Figure Europe Adalimumab Biosimilar Market Market Concentration, in 2019

Figure Asia-Pacific Adalimumab Biosimilar MMarket Concentration, in 2019

Figure South America Adalimumab Biosimilar Market Concentration, in 2019

Figure Middle East & Africa Adalimumab Biosimilar Market Concentration, in 2019

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospital Pharmacy

Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2015-2019, in USD Million

Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2015-2019, in Volume

6.1.2 Demand in Retail Pharmacy

Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2015-2019, in USD Million

Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2015-2019, in Volume

6.1.3 Demand in Online Pharmacy

Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2015-2019, in USD Million

Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2015-2019, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Adalimumab Biosimilar Demand Forecast 2020-2025, by Application, in USD Million

Figure Adalimumab Biosimilar Market Growth 2020-2025, by Application, in USD Million

Figure Adalimumab Biosimilar Market Share in 2025, by Application, in USD Million

Table Adalimumab Biosimilar Demand Forecast 2020-2025, by Application, in Volume

Table Adalimumab Biosimilar Market Growth 2020-2025, by Application, in Volume

Table Adalimumab Biosimilar Market Share in 2025, by Application, in Volume

7 Region Operation

7.1 Regional Production

Table Adalimumab Biosimilar Production 2015-2019, by Region, in USD Million

Table Adalimumab Biosimilar Production 2015-2019, by Region, in Volume

7.2 Regional Market

Table Global Adalimumab Biosimilar Market 2015-2019, by Region, in USD Million

Table Global Adalimumab Biosimilar Market Share 2015-2019, by Region, in USD Million

Table Global Adalimumab Biosimilar Market 2015-2019, by Region, in Volume

Table Global Adalimumab Biosimilar Market Share 2015-2019, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Adalimumab Biosimilar Market Size and Growth 2015-2019, in USD Million

Figure North America Adalimumab Biosimilar Market Size and Growth 2015-2019, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table North America Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Adalimumab Biosimilar Market Size and Growth 2015-2019, in USD Million

Figure Europe Adalimumab Biosimilar Market Size and Growth 2015-2019, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table Europe Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2015-2019, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Adalimumab Biosimilar Market Size and Growth 2015-2019, in USD Million

Figure South America Adalimumab Biosimilar Market Size and Growth 2015-2019, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table South America Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2015-2019, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Adalimumab Biosimilar Market Forecast 2020-2025, by Region, in USD Million

Table Adalimumab Biosimilar Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

List of Table

List of Table

Table Upstream Segment of Adalimumab Biosimilar

Table Application Segment of Adalimumab Biosimilar

Table Global Adalimumab Biosimilar Market 2015-2025, by Application, in USD Million

Table Major Company List of Oral Solution

Table Global Adalimumab Biosimilar Market 2015-2019, by Type, in USD Million

Table Global Adalimumab Biosimilar Market 2015-2019, by Type, in Volume

Table Global Adalimumab Biosimilar Market Forecast 2020-2025, by Type, in USD Million

Table Global Adalimumab Biosimilar Market Forecast 2020-2025, by Type, in Volume

Table AET BioTech Overview List

Table Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim Overview List

Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Coherus Biosciences Overview List

Table Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fujifilm Kyowa Kirin Biologics Overview List

Table Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table LG Life Sciences/Mochida Pharmaceutical Overview List

Table Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Momenta Pharmaceuticals Overview List

Table Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Oncobiologics Overview List

Table Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Samsung Bioepsis Overview List

Table Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sandoz Overview List

Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Zydus Cadila Overview List

Table Business Operation of Zydus Cadila (Sales Revenue, Cost, Gross Margin)

Table Global Adalimumab Biosimilar Sales Revenue 2015-2019, by Company, in USD Million

Table Global Adalimumab Biosimilar Sales Revenue Share 2015-2019, by Company, in USD Million

Table Global Adalimumab Biosimilar Sales Volume 2015-2019, by Company, in Volume

Table Global Adalimumab Biosimilar Sales Volume Share 2015-2019, by Company, in Volume

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Adalimumab Biosimilar Demand Forecast 2020-2025, by Application, in USD Million

Table Adalimumab Biosimilar Demand Forecast 2020-2025, by Application, in Volume

Table Adalimumab Biosimilar Market Growth 2020-2025, by Application, in Volume

Table Adalimumab Biosimilar Market Share in 2025, by Application, in Volume

Table Adalimumab Biosimilar Production 2015-2019, by Region, in USD Million

Table Adalimumab Biosimilar Production 2015-2019, by Region, in Volume

Table Global Adalimumab Biosimilar Market 2015-2019, by Region, in USD Million

Table Global Adalimumab Biosimilar Market Share 2015-2019, by Region, in USD Million

Table Global Adalimumab Biosimilar Market 2015-2019, by Region, in Volume

Table Global Adalimumab Biosimilar Market Share 2015-2019, by Region, in Volume

Table North America Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table North America Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

Table Europe Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table Europe Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

Table Asia-Pacific Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

Table South America Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table South America Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

Table Middle East & Africa Adalimumab Biosimilar Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Adalimumab Biosimilar Market Size 2015-2019, by Country, in Volume

Table Adalimumab Biosimilar Market Forecast 2020-2025, by Region, in USD Million

Table Adalimumab Biosimilar Market Forecast 2020-2025, by Region, in Volume

Table Price Factors List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950